Fanni Fruzsina Geibl

Head of Laboratory - Cellular Neuropsychiatry, Resident physician (Psychiatry and Psychotherapy)

Philipps-Universität Marburg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Neuroscience Neuroscience professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Fanni Fruzsina Geibl is the Head of Laboratory in Cellular Neuropsychiatry and a resident physician specializing in Psychiatry and Psychotherapy at Philipps University of Marburg, Germany. Her research focuses on the intersection of neurodegenerative diseases, particularly Parkinson's disease, with an emphasis on REM sleep behavior disorder and mitochondrial dysfunction. Recent publications include studies on α-synuclein pathology and its impact on neuronal connectivity, as well as investigations into therapeutic approaches for sleep-related symptoms in neurodegenerative disorders.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (4)

Valina Dawson

Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Xiaobo Mao

Associate Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Martin Timo Henrich

Head of Laboratory - Cellular Neuropsychiatry, Resident physician

Philipps-Universität Marburg

GERMANY

View details

Ruiqing Ni

University of Zurich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Fanni Fruzsina Geibl

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

“How to save a marriage”: treatment of REM sleep behavior disorder (RBD) with acetyl-leucine in a patient with Parkinson’s disease

Efficient characterization of multiple binding sites of small molecule imaging ligands on amyloid-beta, tau and alpha-synuclein.

α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease.

Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern-case reports.

Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.

The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease.

Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson's disease.

Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.

Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.

Determinants of seeding and spreading of α-synuclein pathology in the brain

Collaborators (4)

Valina Dawson

Xiaobo Mao

Martin Timo Henrich

Ruiqing Ni

Make your next move.